Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Terho HeikkinenThedi Ziegler


Influenza B virus strains in trivalent influenza vaccines are frequently mismatched to the circulating B strains, but the population-level impact of such mismatches is unknown. We assessed the impact of vaccine mismatch on the epidemiology of influenza B during 12 recent seasonal outbreaks of influenza in Finland. We analyzed all available nationwide data on virologically confirmed influenza infections in all age groups in Finland between 1 July 1999 and 30 June 2012, with the exclusion of the pandemic season of 2009-2010. We derived data on influenza infections and the circulation of different lineages of B viruses during each season from the Infectious Diseases Register and the National Influenza Center, National Institute for Health and Welfare, Finland. A total of 34 788 cases of influenza were recorded. Influenza A accounted for 74.0% and influenza B for 26.0% of all typed viruses. Throughout the 12 seasons, we estimated that 41.7% (3750 of 8993) of all influenza B infections were caused by viruses representing the other genetic lineage than the one in the vaccine. Altogether, opposite-lineage influenza B viruses accounted for 10.8% of all influenza infections in the population, the proportion being highest (16.8%) in chil...Continue Reading


Aug 12, 2000·Journal of Paediatrics and Child Health·A J DaleyD Isaacs
Jan 9, 2003·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Jan 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ville PeltolaOlli Ruuskanen
Sep 16, 2004·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Jun 4, 2008·The Pediatric Infectious Disease Journal·Chia-Yu ChiChing-Chuan Liu
Mar 20, 2009·The Pediatric Infectious Disease Journal·Heli SilvennoinenTerho Heikkinen
Nov 26, 2010·The Lancet Infectious Diseases·Santtu HeinonenTerho Heikkinen
Feb 8, 2011·The Pediatric Infectious Disease Journal·Heli SilvennoinenTerho Heikkinen
Jun 7, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H SilvennoinenT Heikkinen
Jan 19, 2012·Human Vaccines & Immunotherapeutics·Christopher S Ambrose, Myron J Levin
Feb 1, 2012·The Journal of Infectious Diseases·Christopher D PaddockSherif R Zaki
Feb 1, 2012·The Journal of Infectious Diseases·Jonathan A McCullers, Frederick G Hayden
Oct 18, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul K S ChanDavid S C Hui
Oct 23, 2012·Vaccine·Bruce Y LeeAlyssa M Willig
Jan 19, 2013·American Journal of Public Health·W Paul GlezenJohn Oxford
Jan 25, 2013·The New England Journal of Medicine·Joseph Bresee, Frederick G Hayden
Jul 20, 2013·American Journal of Public Health·Roman PabayoIchiro Kawachi
Dec 18, 2013·The New England Journal of Medicine·Lindsey R Baden

❮ Previous
Next ❯


Jan 16, 2016·Antiviral Research·Nadezhda M ZholobakVladimir K Ivanov
Sep 8, 2015·Vaccines·Lei DengXavier Saelens
Feb 19, 2016·Human Vaccines & Immunotherapeutics·Monica TafallaMarije Vonk Noordegraaf-Schouten
Dec 3, 2015·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Eliana Nogueira Castro de BarrosRomulo Colindres
Jun 20, 2015·Human Vaccines & Immunotherapeutics·Nicola PrincipiSusanna Esposito
Apr 23, 2015·The Journal of General Virology·Carolien E van de SandtMarine L B Hillaire
Sep 10, 2015·MMW Fortschritte der Medizin·Peter WutzlerKlaus Wahle
Aug 21, 2015·BMC Infectious Diseases·Anne MosnierUNKNOWN GROG network
May 23, 2015·Human Vaccines & Immunotherapeutics·Iván Martínez-BazUNKNOWN Primary Health Care Sentinel Network and Network for Influenza Surveillance in Hospitals of Navarra
Aug 21, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W Paul Glezen
Sep 1, 2015·Human Vaccines & Immunotherapeutics·Mohammad AleflaliHarunor Rashid
Aug 18, 2016·PloS One·Sivan SharabiMichal Mandelboim
Sep 22, 2016·Influenza and Other Respiratory Viruses·Aye M MoaChandini R MacIntyre
Jan 10, 2017·Scientific Reports·Daihai HeDuo Yu
Mar 28, 2017·PloS One·Saverio CainiUNKNOWN Global Influenza B Study group–Latin America
Jun 15, 2017·Expert Review of Pharmacoeconomics & Outcomes Research·Pieter T de BoerMaarten J Postma
Mar 3, 2018·Influenza and Other Respiratory Viruses·Donatella PanattoDaniela Amicizia
Mar 7, 2018·Antimicrobial Agents and Chemotherapy·Adam VigilMichael Wittekind
Nov 22, 2017·Expert Review of Vaccines·Viviane Gresset-BourgeoisSandrine I Samson
Oct 31, 2017·Nature Reviews. Microbiology·Velislava N Petrova, Colin A Russell
Jul 3, 2015·Journal of Virology·I-Ching SamGavin J D Smith
Apr 12, 2016·Tuberculosis and Respiratory Diseases·Jae Yeol Kim
Feb 24, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Gautham K RaoWendy G Halpern
Dec 8, 2015·Expert Review of Vaccines·Rafik Bekkat-BerkaniBruce L Innis
Feb 2, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Manjusha GaglaniBrendan Flannery
Sep 19, 2019·Human Vaccines & Immunotherapeutics·Timo VesikariViviane Gresset-Bourgeois
Apr 8, 2020·Human Vaccines & Immunotherapeutics·Alberto Pérez-RubioJose María Eiros Bouza
Feb 25, 2020·The Pediatric Infectious Disease Journal·Janna-Maija MattilaTerho Heikkinen

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Related Papers

Human Vaccines & Immunotherapeutics
Christopher S Ambrose, Myron J Levin
The Journal of Nursing Education
Janis P Bellack
© 2021 Meta ULC. All rights reserved